A new at-home diagnostic device concept demonstrates how somatic cell count (SCC) in breastmilk can be measured to identify mastitis before symptoms appear. Hermione Blakiston, an innovation and R&D consultant at Sagentia Medical, says the concept, named celleste, was designed with empathy, ease of
BrightHeart, a specialist in AI-driven prenatal ultrasound, has announced it has received the CE mark for its flagship medical devices, enabling commercialisation of the B-Right AI Platform across the European Union. The company will make its European debut at the Fetal Medicine Foundation (FMF) Wor
Spotlight Medical, a Paris-based oncology diagnostics company, has announced that myStage Dx has received CE marking under the European Union In Vitro Diagnostic Medical Devices Regulation (IVDR, Regulation (EU) 2017/746). The milestone advances Spotlight Medical’s European commercialisation strateg
Jeff Houtz, global sr. product manager at QuidelOrtho, explores the challenges women face in the diagnosis of thyroid conditions, including biases in diagnosis and screening barriers. Why do thyroid conditions continue to be so difficult to diagnose, particularly in women? So, I think probably the e
A digital perinatal mental health pilot for Black and ethnically minoritised women has helped women access support faster, complete therapy at higher rates, and recover more successfully than national averages. The partnership between digital tech company Dr-Julian and The Essential Baby Company Ltd
With average time to endometriosis diagnosis in the UK now 9 years 4 months, Hermione Blakiston from Sagentia Medical explains how clinical adoption of menstrual blood as a diagnostic sample could help accelerate the care pathway. The gold standard for diagnosing endometriosis – laparoscopy – requir
Cyclana Bio, a biotechnology company pioneering tissue-level approaches to women’s health, has announced it has received Health Research Authority (HRA) and Research Ethics Committee (REC) approval for its 500-patient clinical observational study, PEMP (Predicting Endometriosis Mechanisms and Popula
Calla Lily Clinical Care, a women’s health-focused medical technology company, has announced dosing of the first patients in the FREEDOM clinical trial. The study, funded by the National Institute for Health and Care Research (NIHR), is evaluating 400mg progesterone Callavid in patients diagnosed wi
Serac Healthcare Limited, a clinical radiopharmaceutical company developing an innovative molecular imaging agent, 99mTc-maraciclatide, and the Nuffield Department of Women’s & Reproductive Health at the University of Oxford announce the journal publication of Phase 2 data from the “Detecting Endome
Women who have experienced pregnancy loss now have access to a dedicated, all-in-one space for support, as pregnancy and postnatal wellbeing app Carea launches its new digital tool to address the long-overlooked gap in clinical guidance. One in four women will experience a miscarriage during their r
Cartherics Pty, a biotechnology company developing off-the-shelf immune cell therapies for high-impact women’s diseases, including ovarian cancer and endometriosis, and Catalent, a company enabling the development and supply of better treatments for patients worldwide, has announced an enhanced part
To celebrate International Women’s Day, Olivia Friett, editor of FemTech on Med-Tech Insights, listens back to The FemTech Series podcast and shares some of her favourite, and most inspiring, moments from the conversations she’s had with women across the sector. Read quotes from Stiliyana Minkovska
